Medicare Enrolled
Dr. Thomas Bradley, MD, PHD
Hematology & Oncology · Monterey, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bradley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bradley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bradley
Dr. Thomas Bradley is a hematology & oncology specialist in Monterey, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bradley performed 2,010 Medicare services across 887 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bradley received a total of $8,608 from 60 pharmaceutical and/or device companies across 426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bradley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 40% volume in CA
$8,608 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,010
Medicare services
Top 40% in CA for hematology & oncology
887
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,011 | $93 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
573 | $144 | $275 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
167 | $98 | $175 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
93 | $26 | $99 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
88 | $143 | $290 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
31 | $140 | $243 |
| New patient office visit, complex (60-74 min) | 19 | $174 | $329 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
16 | $95 | $200 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
12 | $80 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,608
Total received (2018-2024)
Avg $1,230/year across 7 years
Top 34% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
426
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,493 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,293
2023
$1,035
2022
$1,097
2021
$1,006
2020
$1,216
2019
$1,632
2018
$1,329
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$276
AstraZeneca Pharmaceuticals LP
$173
Novartis Pharmaceuticals Corporation
$90
Celgene Corporation
$73
Astellas Pharma US Inc
$58
Eisai Inc.
$55
Secura Bio, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$43
Blueprint Medicines Corporation
$37
Janssen Pharmaceuticals, Inc
$36
Regeneron Healthcare Solutions, Inc.
$32
Merck Sharp & Dohme LLC
$31
Exelixis Inc.
$30
BeiGene USA, Inc.
$30
PFIZER INC.
$30
Coherus Biosciences Inc.
$29
ADC Therapeutics America, Inc.
$27
Stemline Therapeutics Inc.
$27
PharmaEssentia USA Corporation
$26
SOBI, INC
$26
Daiichi Sankyo Inc.
$26
Aveo Pharmaceuticals, Inc.
$25
Novocure Inc.
$23
ABBVIE INC.
$20
ARRAY BIOPHARMA INC
$16
Rigel Pharmaceuticals, Inc.
$6
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,175
E.R. Squibb & Sons, L.L.C.
$1,034
PFIZER INC.
$569
Novartis Pharmaceuticals Corporation
$525
AstraZeneca Pharmaceuticals LP
$417
Astellas Pharma US Inc
$305
Eisai Inc.
$301
Lilly USA, LLC
$282
Genentech USA, Inc.
$244
Takeda Pharmaceuticals U.S.A., Inc.
$218
Exelixis Inc.
$216
Amgen Inc.
$207
Daiichi Sankyo Inc.
$204
Seagen Inc.
$176
Merck Sharp & Dohme Corporation
$173
GlaxoSmithKline, LLC.
$160
Taiho Oncology, Inc.
$152
Janssen Pharmaceuticals, Inc
$151
Celgene Corporation
$145
Foundation Medicine, Inc.
$122
Bayer HealthCare Pharmaceuticals Inc.
$107
Rigel Pharmaceuticals, Inc.
$105
GENZYME CORPORATION
$104
Alexion Pharmaceuticals, Inc.
$87
ARRAY BIOPHARMA INC
$84
Stemline Therapeutics Inc.
$77
Secura Bio, Inc.
$71
Blueprint Medicines Corporation
$71
Incyte Corporation
$66
ABBVIE INC.
$61
Gilead Sciences, Inc.
$55
ADC Therapeutics America, Inc.
$55
Regeneron Healthcare Solutions, Inc.
$54
Merck Sharp & Dohme LLC
$51
AbbVie Inc.
$49
AbbVie, Inc.
$46
EISAI INC.
$45
Collegium Pharmaceutical, Inc.
$44
Kite Pharma, Inc.
$43
Karyopharm Therapeutics Inc.
$38
Genentech, Inc.
$38
Seattle Genetics, Inc.
$35
EMD Serono, Inc.
$31
BeiGene USA, Inc.
$30
Coherus Biosciences Inc.
$29
CTI BioPharma Corp.
$27
Radius Health, Inc.
$26
PharmaEssentia USA Corporation
$26
SOBI, INC
$26
Sobi, Inc
$26
Pharmacyclics LLC, An AbbVie Company
$26
Aveo Pharmaceuticals, Inc.
$25
AVEO Pharmaceuticals, Inc.
$24
Epizyme, Inc.,
$24
Novocure Inc.
$23
Agios Pharmaceuticals, Inc.
$23
Servier Pharmaceuticals LLC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Dova Pharmaceuticals
$18
AMAG Pharmaceuticals, Inc.
$13
Top 3 companies account for 32.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Avastin · BAVENCIO · BESREMI · BLENREP · BRAFTOVI · CABOMETYX · CALQUENCE · CAMZYOS · CARVYKTI · COPIKTRA · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MYLOTARG · NINLARO · Nplate · Nubeqa · OPDIVO · Optune · Orserdu · PADCEV · PROMACTA · Padcev · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Rezlidhia · SCEMBLIX · SPRYCEL · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · Tavalisse · Trodelvy · Tymlos · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTAMPZA · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
12
Per 100K population
2.8
County median income
$94,486
Nearest hospital
COMMUNITY HOSPITAL OF THE MONTEREY PENINSULA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bradley is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bradley experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bradley performed 1,011 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bradley receive payments from pharmaceutical companies?
Yes. Dr. Bradley received a total of $8,608 from 60 companies across 426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bradley's costs compare to other hematology & oncology specialists in Monterey?
Dr. Bradley's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bradley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Monterey
Browse hematology & oncology specialists in Monterey ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology